Expands on the previously granted patents covering the use of REQORSA in combination with immune checkpoint inhibitors Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing...
Credit: ACS Central Science (2024). DOI: 10.1021/acscentsci.4c00559 Sneaking by cancer’s defenses, by disguising tumor-fighting antibodies inside the molecules cancer uses to nourish tumor growth, is the basis of a novel therapy from Yale Cancer Center...
According to SkyQuest, the global Cancer Gene Therapy Market size was valued at USD 2.38 billion in 2022 and is poised to grow from USD 2.86 billion in 2023 to USD 12.63 billion by 2031, growing at a CAGR of 20.42% in the forecast period (2024-2031). Cancer has...
Visualized DNA damage (green) in human breast cancer cells (blue). Credit: Garvan Institute Using artificial intelligence, Garvan Institute researchers have found potential cancer drivers hidden in so-called ‘junk’ regions of DNA, opening up possibilities...
Immunotherapies have become a key treatment area within oncology. In 2023 the global market size of this type of treatment was estimated to be worth $118.9 billion, and this is expected to more than double over the next decade, suggests Statista. Many of the big...
